ESTA: establishmentlabs.com Expected earnings per share growth for next year
Establishment Labs leverages a global sales reach across 80 countries, mitigating risks through reconstructive medicine. Motiva products act as a cash cow, ensuring high operating profit. Physician trust in safe implants guarantees growth in the aesthetics segment. On GURU.Markets, this line chart, serving as a benchmark for the consensus EPS forecast for the coming year, reflects a trend where the 91.70 level captures the current state.
Analytical breakdowns for establishmentlabs.com (ESTA)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Establishment Labs|ESTA - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Establishment Labs Holdings Inc.|ESTA - Company Total Debt Obligations|Debts to Book Capitalization Establishment Labs|ESTA - Company Long-Term Liabilities|Company Short-Term Debts Establishment Labs|Quick Liquidity establishmentlabs.com
- net income and valuation ratios data:
ESTA - Company Net Income|Future Profit Establishment Labs|ESTA - Company Value to Net Income|Forward P/E Multiple Establishment Labs|ESTA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Establishment Labs|ESTA - Operating profit before depreciation charges|Net earnings per share for the last 12 months Establishment Labs|ESTA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth establishmentlabs.com|ESTA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Establishment Labs
Initial company analysis:Motiva, ESTA
Asset undervaluation risks are minimized through the analysis of one-year forward consensus earnings forecasts, which measure expected EPS dynamics to determine entry points. By tracking the annual EPS forecast for Establishment Labs (ESTA) on GURU.Markets, an investor can see how the company's expansion into the US aesthetic medicine market and the launch of innovations transform analytical expectations into a real inflow of liquidity.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|TMDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATEC|AORT (Artivion) - Earnings growth forecast for next year|Enovis Corp (ENOV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year IART|Expected earnings per share growth for next year iLet Bionic Pancreas BBNX|Earnings growth forecast for next year IRMD (IRADIMED CORPORATION)|Earnings growth forecast for next year embecta.com EMBC|TNDM - Net earnings per share growth forecast for next year|AXGN: Net earnings per share growth forecast for next year|SIBN (SI-BONE Corp) - Expected earnings per share growth for next year|Orthofix Corp - Expected earnings per share trend next year|BVS (Bioventus Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year OrthoPediatrics Inc. KIDS|Net earnings per share growth forecast for next year Treace Medical Concepts, Inc. (TMCI)|Blade Air Mobility (SRTA) - Net earnings per one share growth forecast for next year|Carlsmed Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year RxSight Ophthalmic RXST|ClearPoint - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year stereotaxis.com STXS|Neuronetics (STIM) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year SGHT (Sight Sciences Inc.)|Net earnings per share growth forecast for next year Orchestra BioMed, Inc.|Expected earnings per share growth for next year Anika (ANIK)|Earnings growth forecast for next year NSPR|ZJYL - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Vivani Medical VANI|XTNT: Projected earnings per share growth rate for next year|NMTC: Expected earnings per share growth for next year|Modular Medical - Projected earnings per share increase next year|MYO: Earnings growth forecast for next year|Expected net earnings per share growth next year envoymedical.com (COCH)|Net earnings per share growth forecast for next year Vivos Therapeutics, Inc.|enVVeno Medical Corporation (NVNO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SINT (Sintx Technologies)|Projected earnings per share increase next year TNON|Earnings growth forecast for next year LFWD (ReWalk Robotics Ltd.)|Earnings growth forecast for next year Autonomix Medical Inc. AMIX|INVO Fertility - Earnings growth forecast for next year|BBLG: Net earnings per share growth forecast for next year|Axonics Modulation Technologies (AXNX) - Net earnings per share growth forecast for next year|BIOL (Biolase Inc.) - Net earnings per share growth forecast for next year|DYNT (Dynatronics Corp) - Earnings growth forecast for next year|Paragon 28 Corp (FNA) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year INVO Bioscience, Inc. (INVO)
